Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With Olaparib+Abiraterone

Clinical trial NCT06457854 · WITHDRAWN

Trial details

NCT number: NCT06457854
Sponsor: AstraZeneca
Status: WITHDRAWN
Study type: OBSERVATIONAL

Prostatic Neoplasms

Start date: 2025-01-01
Primary completion: 2025-02-04
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.